Distinct pathways leading to TDP-43-induced cellular dysfunctions

Human Molecular Genetics

Volumn 23, Issue 16, 2014, Pages 4345-4356

  Yamashita, Makiko ^a   Nonaka, Takashi ^a   Hirai, Shinobu ^a   Miwa, Akiko ^a   Okado, Haruo ^a   Arai, Tetsuaki ^b   Hosokawa, Masato ^a   Akiyama, Haruhiko ^a   Hasegawa, Masato ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; LENTIVIRUS VECTOR; RNA POLYMERASE II; TAR DNA BINDING PROTEIN; TRANSCRIPTION FACTOR SP1; CREB1 PROTEIN, HUMAN; DNA BINDING PROTEIN; PEPTIDE; SP1 PROTEIN, HUMAN; TDP-43 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CELL NUCLEUS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; FRONTOTEMPORAL DEMENTIA; G2 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TDP 43 PROTEINOPATHY; TRANSCRIPTION REGULATION; AMYOTROPHIC LATERAL SCLEROSIS; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; NERVE CELL; TUMOR CELL LINE;

AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA-BINDING PROTEINS; FRONTOTEMPORAL DEMENTIA; G2 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION; HUMANS; METABOLIC NETWORKS AND PATHWAYS; NEURONS; PEPTIDES; RNA POLYMERASE II; SP1 TRANSCRIPTION FACTOR;

EID: 84904750994     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu152     Document Type: Article

References (52)

1. Arai, T., Hasegawa, M., Akiyama,H., Ikeda, K., Nonaka, T., Mori, H.,Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y. et al. (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun., 351, 602-611.
2. Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., Bruce, J., Schuck, T., Grossman, M., Clark, C.M. et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314, 130-133.
3. Ayala, Y.M., De Conti, L., Avendano-Vazquez, S.E., Dhir, A., Romano, M., D'Ambrogio, A., Tollervey, J., Ule, J., Baralle, M., Buratti, E. et al. (2011) TDP-43regulates itsmRNAlevels through a negative feedback loop.EMBO J., 30, 277-288.
4. Ayala, Y.M., Zago, P., D'Ambrogio, A., Xu, Y.F., Petrucelli, L., Buratti, E. and Baralle, F.E. (2008) Structural determinants of the cellular localization and shuttling of TDP-43. J. Cell Sci., 121, 3778-3785.
5. Buratti, E. and Baralle, F.E. (2008) Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front. Biosci., 13, 867-878.
6. Ou, S.H., Wu, F., Harrich, D., Garcia-Martinez, L.F. and Gaynor, R.B. (1995) Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TARDNAsequence motifs. J. Virol., 69, 3584-3596.
7. Wang, I.F., Reddy, N.M. and Shen, C.K. (2002) Higher order arrangement of the eukaryotic nuclear bodies. Proc. Natl. Acad. Sci.USA, 99, 13583-13588.
8. Ayala, Y.M., Pantano, S., D'Ambrogio, A., Buratti, E., Brindisi, A., Marchetti, C., Romano,M. and Baralle, F.E. (2005) Human, Drosophila, and C. elegans TDP43: nucleic acid binding properties and splicing regulatory function. J. Mol. Biol., 348, 575-588.
9. Buratti, E. and Baralle, F.E. (2001) Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator ofCFTRexon 9. J. Biol. Chem., 276, 36337-36343.
10. Buratti, E., Brindisi, A., Giombi, M., Tisminetzky, S., Ayala, Y.M. and Baralle, F.E. (2005) TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J. Biol. Chem., 280, 37572-37584.
11. Wang, I.F., Wu, L.S. and Shen, C.K. (2008) TDP-43: an emerging new player in neurodegenerative diseases. Trends Mol. Med., 14, 479-485.
12. Hasegawa, M., Arai, T., Nonaka, T., Kametani, F., Yoshida, M., Hashizume, Y., Beach, T.G., Buratti, E., Baralle, F., Morita, M. et al. (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol., 64, 60-70.
13. Hasegawa, M., Nonaka, T., Tsuji, H., Tamaoka, A., Yamashita, M., Kametani, F., Yoshida, M., Arai, T. and Akiyama, H. (2011) Molecular dissection of TDP-43 proteinopathies. J. Mol. Neurosci., 45, 480-485.
14. Gitcho, M.A., Bigio, E.H., Mishra, M., Johnson, N., Weintraub, S., Mesulam, M., Rademakers, R., Chakraverty, S., Cruchaga, C., Morris, J.C. et al. (2009) TARDBP3′-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy. Acta Neuropathol., 118, 633-645.
15. Johnson, B.S., McCaffery, J.M., Lindquist, S. and Gitler, A.D. (2008) A yeastTDP-43proteinopathy model: exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc. Natl. Acad. Sci. USA, 105, 6439-6444.
16. Tatom, J.B., Wang, D.B., Dayton, R.D., Skalli, O., Hutton, M.L., Dickson, D.W. and Klein, R.L. (2009) Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrig's disease in rats via TDP-43 overexpression. Mol. Ther., 17, 607-613.
17. Wils, H., Kleinberger, G., Janssens, J., Pereson, S., Joris, G., Cuijt, I., Smits, V., Ceuterick-de Groote, C., Van Broeckhoven, C. and Kumar-Singh, S. (2010) TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. USA, 107, 3858-3863.
18. Guo, W., Chen, Y., Zhou, X., Kar, A., Ray, P., Chen, X., Rao, E.J., Yang, M., Ye, H., Zhu, L. et al. (2011) An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity. Nat. Struct. Mol. Biol., 18, 822-830.
19. Igaz, L.M., Kwong, L.K., Chen-Plotkin, A., Winton, M.J., Unger, T.L., Xu, Y., Neumann, M., Trojanowski, J.Q. and Lee, V.M. (2009) Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 proteinopathies. J. Biol. Chem., 284, 8516-8524.
20. Nonaka, T., Kametani, F., Arai, T., Akiyama, H. and Hasegawa, M. (2009) Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum. Mol. Genet., 18, 3353-3364.
21. Zhang, Y.J., Xu, Y.F., Cook, C., Gendron, T.F., Roettges, P., Link, C.D., Lin, W.L., Tong, J., Castanedes-Casey, M., Ash, P. et al. (2009) Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl. Acad. Sci. USA, 106, 7607-7612.
22. Nonaka, T., Masuda-Suzukake, M., Arai, T., Hasegawa, Y., Akatsu, H., Obi, T., Yoshida, M., Murayama, S., Mann, D.M., Akiyama, H. et al. (2013) Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep., 4, 124-134.
23. Nonaka, T., Arai, T., Buratti, E., Baralle, F.E., Akiyama, H. and Hasegawa, M. (2009) Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells. FEBS Lett., 583, 394-400.
24. Okazawa, H. (2003) Polyglutamine diseases: a transcription disorder? Cell Mol. Life Sci., 60, 1427-1439.
25. Sugars, K.L. and Rubinsztein, D.C. (2003) Transcriptional abnormalities in Huntington disease. Trends Genet., 19, 233-238.
26. Dunah, A.W., Jeong, H., Griffin, A., Kim, Y.M., Standaert, D.G., Hersch, S.M., Mouradian, M.M., Young, A.B., Tanese, N. and Krainc, D. (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science, 296, 2238-2243.
27. Mantamadiotis, T., Lemberger, T., Bleckmann, S.C., Kern, H., Kretz, O., Martin Villalba, A., Tronche, F., Kellendonk, C., Gau, D., Kapfhammer, J. et al. (2002) Disruption of CREB function in brain leads to neurodegeneration. Nat. Genet., 31, 47-54.
28. Furukawa, Y., Kaneko, K., Watanabe, S., Yamanaka, K. and Nukina, N. (2011) A seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions. J. Biol. Chem., 286, 18664-18672.
29. Chiang, P.M., Ling, J., Jeong, Y.H., Price, D.L., Aja, S.M. and Wong, P.C. (2010) Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism. Proc. Natl. Acad. Sci. USA, 107, 16320-16324.
30. Kraemer, B.C., Schuck, T., Wheeler, J.M., Robinson, L.C., Trojanowski, J.Q., Lee, V.M. and Schellenberg, G.D. (2010) Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Acta. Neuropathol., 119, 409-419.
31. Sephton, C.F., Good, S.K., Atkin, S., Dewey, C.M., Mayer, P. 3rd, Herz, J. and Yu, G. (2010) TDP-43 is a developmentally regulated protein essential for early embryonic development. J. Biol. Chem., 285, 6826-6834.
32. Wu, L.S., Cheng, W.C., Hou, S.C., Yan, Y.T., Jiang, S.T. and Shen, C.K. (2010) TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis. Genesis, 48, 56-62.
33. Xu, Y.F., Gendron, T.F., Zhang, Y.J., Lin, W.L., D'Alton, S., Sheng, H., Casey, M.C., Tong, J., Knight, J., Yu, X. et al. (2010) Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J. Neurosci., 30, 10851-10859.
34. Freibaum, B.D., Chitta, R.K., High, A.A. and Taylor, J.P. (2010) Global analysis of TDP-43 interacting proteins reveals strong association withRNA splicing and translation machinery. J. Proteome Res., 9, 1104-1120.
35. Kuo, P.H., Doudeva, L.G., Wang, Y.T., Shen, C.K. and Yuan, H.S. (2009) Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Nucleic Acids Res., 37, 1799-1808.
36. Polymenidou, M., Lagier-Tourenne, C., Hutt, K.R., Huelga, S.C., Moran, J., Liang, T.Y., Ling, S.C., Sun, E.,Wancewicz, E., Mazur, C. et al. (2011) Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci., 14, 459-468.
37. Tollervey, J.R., Curk, T., Rogelj, B., Briese, M., Cereda, M., Kayikci, M., Konig, J., Hortobagyi, T., Nishimura, A.L., Zupunski, V. et al. (2011) Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci., 14, 452-458.
38. Ishihara, T., Ariizumi, Y., Shiga, A., Kato, T., Tan, C.F., Sato, T., Miki, Y., Yokoo, M., Fujino, T., Koyama, A. et al. (2013) Decreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis. Hum. Mol. Genet., 22, 4136-4147.
39. Bose, J.K., Wang, I.F., Hung, L., Tarn, W.Y. and Shen, C.K. (2008) TDP-43 overexpression enhances exon 7 inclusion during the survival of motor neuron pre-mRNA splicing. J. Biol. Chem., 283, 28852-28859.
40. Buratti, E., Dork, T., Zuccato, E., Pagani, F., Romano, M. and Baralle, F.E. (2001) Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J., 20, 1774-1784.
41. Fiesel, F.C., Weber, S.S., Supper, J., Zell, A. and Kahle, P.J. (2012) TDP-43 regulates global translational yield by splicing of exon junction complex component SKAR. Nucleic Acids Res., 40, 2668-2682.
42. Shiga, A., Ishihara, T., Miyashita, A., Kuwabara, M., Kato, T., Watanabe, N., Yamahira, A., Kondo, C., Yokoseki, A., Takahashi, M. et al. (2012) Alteration of POLDIP3 splicing associated with loss of function of TDP-43 in tissues affected with ALS. PLoS One, 7, e43120.
43. Colombrita, C., Onesto, E., Megiorni, F., Pizzuti, A., Baralle, F.E., Buratti, E., Silani, V. and Ratti, A. (2012) TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells. J. Biol. Chem., 287, 15635-15647.
44. Rabin, S.J., Kim, J.M., Baughn, M., Libby, R.T., Kim, Y.J., Fan, Y., Libby, R.T., La Spada, A., Stone, B. and Ravits, J. (2010) Sporadic ALS has compartment-specific aberrant exon splicing and altered cell-matrix adhesion biology. Hum. Mol. Genet., 19, 313-328.
45. Burghes, A.H. and Beattie, C.E. (2009) Spinal muscular atrophy:whydo low levels of survival motor neuron protein make motor neurons sick? Nat. Rev. Neurosci., 10, 597-609.
46. Jady, B.E., Darzacq, X., Tucker, K.E., Matera, A.G., Bertrand, E. and Kiss, T. (2003) Modification of Sm small nuclear RNAs occurs in the nucleoplasmic Cajal body following import from the cytoplasm. EMBO J., 22, 1878-1888.
47. Mao, Y.S., Zhang, B. and Spector, D.L. (2011) Biogenesis and function of nuclear bodies. Trends Genet., 27, 295-306.
48. Tsuiji, H., Iguchi, Y., Furuya, A., Kataoka, A., Hatsuta, H., Atsuta, N., Tanaka, F., Hashizume, Y., Akatsu, H., Murayama, S. et al. (2013) Spliceosome integrity is defective in the motor neuron diseases ALS and SMA. EMBO Mol. Med., 5, 221-234.
49. van Blitterswijk, M. and Landers, J.E. (2010) RNA processing pathways in amyotrophic lateral sclerosis. Neurogenetics, 11, 275-290.
50. Inukai, Y., Nonaka, T., Arai, T., Yoshida, M., Hashizume, Y., Beach, T.G., Buratti, E., Baralle, F.E., Akiyama, H., Hisanaga, S. et al. (2008) Abnormal phosphorylation of Ser409/410 of TDP-43 inFTLD-Uand ALS. FEBSLett., 582, 2899-2904.
51. Hirai, S., Miwa, A., Ohtaka-Maruyama, C., Kasai, M., Okabe, S., Hata, Y. and Okado, H. (2012) RP58 controls neuron and astrocyte differentiation by downregulating the expression of Id1-4 genes in the developing cortex. EMBO J., 31, 1190-1202.
52. Fujiki, T., Miura, T., Maura, M., Shiraishi, H., Nishimura, S., Imada, Y., Uehara, N., Tashiro, K., Shirahata, S. and Katakura, Y. (2007) TAK1 represses transcription of the human telomerase reverse transcriptase gene. Oncogene, 26, 5258-5266.